Jeffrey Walch Score: 39
Analyst at
Bernstein
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+0.6%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
57%
4 W / 3 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
100%
1 W / 0 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 1 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 1 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
50%
1 W / 1 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
67%
2 W / 1 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
50%
2 W / 2 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 25, 2026 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$376.00
Est. +59%
|
$236.01 | $271.12 |
Pending
|
$266.11
+12.8%
|
| Aug 21, 2026 |
Revolution Medicines Inc
RVMD
|
SELL |
$179.00
Est. +15%
|
$211.74 | $198.94 (Low) |
Pending
|
$210.02
+0.8%
|
| Aug 14, 2026 |
Regeneron Pharmaceuticals, Inc.
REGN
|
SELL |
$756.00
Est. +5%
|
$799.46 | $779.08 (Low) |
Pending
|
$827.72
-3.5%
|
| Aug 11, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$608.00
Est. +15%
|
$530.29 | $560.25 |
Pending
|
$546.12
+3.0%
|
| May 21, 2026 |
Revolution Medicines Inc
RVMD
|
SELL |
$151.00
Est. +2%
|
$153.73 | $141.45 (Low) |
Target Met
|
$210.02
-36.6%
|
| May 21, 2026 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$221.00
Est. +42%
|
$155.50 | $186.12 |
Pending
|
$155.64
+0.1%
|
Alnylam Pharmaceuticals Inc
ALNY
Aug 25, 2026
Signal & Target
BUY
$376.00
Start Price
$236.01
Best Price (1Y)
$271.12
Current Price
$266.11
Return
+12.8%
Revolution Medicines Inc
RVMD
Aug 21, 2026
Signal & Target
SELL
$179.00
Start Price
$211.74
Best Price (1Y)
$198.94
Current Price
$210.02
Return
+0.8%
Regeneron Pharmaceuticals, Inc.
REGN
Aug 14, 2026
Signal & Target
SELL
$756.00
Start Price
$799.46
Best Price (1Y)
$779.08
Current Price
$827.72
Return
-3.5%
Vertex Pharmaceuticals, Inc.
VRTX
Aug 11, 2026
Signal & Target
BUY
$608.00
Start Price
$530.29
Best Price (1Y)
$560.25
Current Price
$546.12
Return
+3.0%
Revolution Medicines Inc
RVMD
May 21, 2026
Signal & Target
SELL
$151.00
Start Price
$153.73
Best Price (1Y)
$141.45
Current Price
$210.02
Return
-36.6%
Neurocrine Biosciences, Inc.
NBIX
May 21, 2026
Signal & Target
BUY
$221.00
Start Price
$155.50
Best Price (1Y)
$186.12
Current Price
$155.64
Return
+0.1%